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Abstract
Background: Chlorhexidine (CHG) penetrates poorly into skin. The purpose of this study was to compare the depth
of CHG skin permeation from solutions containing either 2% (w/v) CHG and 70% (v/v) isopropyl alcohol (IPA) or 2%
(w/v) CHG, 70% (v/v) IPA and 2% (v/v) 1,8-cineole.
Methods: An ex-vivo study using Franz diffusion cells was carried out. Full thickness human skin was mounted
onto the cells and a CHG solution, with or without 2% (v/v) 1,8-cineole was applied to the skin surface. After
twenty-four hours the skin was sectioned horizontally in 100 μm slices to a depth of 2000 μm and the concentration of
CHG in each section quantified using high performance liquid chromatography (HPLC). The data were analysed with
repeated measures analysis of variance.
Results: The concentration of CHG in the skin on average was significantly higher (33.3% [95%, CI 1.5% - 74.9%]) when
a CHG solution which contained 1,8-cineole was applied to the skin compared to a CHG solution which did not
contain this terpene (P = 0.042).
Conclusions: Enhanced delivery of CHG can be achieved in the presence of 1,8-cineole, which is the major
component of eucalyptus oil. This may reduce the numbers of microorganisms located in the deeper layers of the skin
which potentially could decrease the risk of surgical site infection.
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Background
Most pathogens that cause surgical site infection are en-
dogenous, primarily from the patient’s skin [1]. Chlorhexidine
(CHG) is often recommended for skin antisepsis prior to
invasive procedures [2], http://hcai.dh.gov.uk/files/2011/03/
2011-03-14-HII-Prevent-Surgical-Site-infection-FINAL.pdf
however it penetrates poorly into skin [3, 4]. This may re-
flect binding of antiseptic compounds including CHG to
intercellular lipids in the stratum corneum [5]. Endogen-
ous microorganisms may therefore persist in the deeper
layers of the skin despite the application of topical antisep-
tics such as CHG. It is therefore important to determine
methods for increasing the penetration of CHG into hu-
man skin to potentially facilitate eradication of these
microorganisms during application of antiseptics and sub-
sequently reduce the risk of infection.
Eucalyptus oil has been successfully used as a skin
penetration enhancer to deliver drugs such as steroid
hormones [6]. Interestingly, this oil also enhances the
delivery of CHG into the epidermis and dermis [7]. In
addition eucalyptus oil exhibits antimicrobial activity
and in combination with CHG acts synergistically [8, 9].
Whilst eucalyptus oil has exhibited a more potent anti-
microbial activity than 1,8 cineole in suspension tests,
1,8 cineole combined with CHG demonstrates a syner-
gistic effect in both suspension and biofilm tests [10].
Since the composition of crude eucalyptus oil can vary, a
purified solution of the main constituent terpene, 1,8
cineole may offer a potential defined alternative to both
enhance CHG intradermal delivery as well as enhance
antimicrobial activity. This is also supported by the pre-
vious observations that 1,8 cineole is a highly effective
penetration enhancer for both 5-fluorouracil and estra-
diol [11]. The mechanism by which terpenes enhance
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skin permeation is thought to be by interaction with
lipids present in the intercellular region of the stratum
corneum [12, 13].
Since 1,8-cineole enhances skin permeation of some
drugs and is the main constituent of eucalyptus oil,
which enhances CHG penetration, we hypothesised that
1,8-cineole will enhance the skin penetration of CHG.
The objective of this present study was therefore to
quantify CHG penetration into human skin following
application of 2% (w/v) CHG and 70% (v/v) isopropyl al-
cohol (IPA) with or without the addition of 2% (v/v) 1,8-
cineole. To our knowledge, this is the first evaluation of
potential enhancement of skin penetration of CHG using
1,8-cineole.
Methods
Donor skin
Following donor consent, full thickness human skin was
obtained from three women aged 51, 52, and 53 years. All
skin was excess abdominal tissue following deep inferior
epigastric perforators (DIEP) flap surgery for breast recon-
struction and was frozen at −20 °C on the day of excision
and used within four weeks. Ethics committee approval
was granted by NRES Committee West Midlands, UK
(REC: 14/WS/1012). All skin donors consented for their
tissue to be used in research.
Skin penetration of CHG using an ex -vivo skin model
Studies were performed as in previous ex vivo skin pene-
tration investigations undertaken by our group [3, 7]. In
brief, the receptor compartments of Franz diffusion cells
were filled with 15 mL of sterile PBS and maintained at
37 °C. Eighteen pieces of full thickness skin (six pieces
from each of three donors) measuring 3 cm × 3 cm were
thawed before mounting onto the cells with the stratum
corneum facing upwards. Any entrapped air between the
skin and the receptor fluid was removed. The skin sur-
face was blotted dry and left to equilibrate for 30 min.
Two of the skin samples from each donor had 100 μL of a
solution containing 2% (w/v) CHG (Sigma Aldrich, Poole,
UK) and 70% (v/v) IPA (Fisher Scientific, Loughborough,
UK) applied to the surface and two skin samples from
each donor had 100 μL of a solution containing 2% (w/v)
CHG, 70% (v/v) IPA and 2% (v/v) 1,8-cineole (Sigma
Aldrich, Poole, UK) applied. The solutions were spread
evenly across the skin surface (3.14 cm2) and left at room
temperature for 24 h. The two remaining skin samples
from each donor were mounted onto the Franz cells with-
out the application of antiseptic. These were used to quan-
tify background CHG levels present in the skin as all
donor patients received pre-operative skin preparation
with 2% (w/v) CHG in 70% (v/v) IPA [ChloraPrep® Care-
Fusion UK Ltd., Basingstoke, UK] prior to skin excision.
The skin samples were frozen with a cryospray (Leica,
Milton Keynes, UK) and three punch biopsies (7 mm in
diameter, totalling an area of 1.15 cm2) removed from
each sample. This equated to approximately 732.5 μg of
CHG applied to each punch biopsy area. In comparison,
when ChloraPrep® one-step applicators are used in clin-
ical situations, according to the manufacturers’ instruc-
tions, a minimum of 22.98 μL 2% (w/v) antiseptic
solution (equal to 459.6 μg CHG) per cm2 of skin is
delivered. The solution used in our study therefore pro-
vided a comparable level of CHG to that by Chlora-
Prep® in the clinical scenario. Skin biopsies were
subsequently sectioned horizontally with a cryotome
(Leica, Milton Keynes, UK) into 100 μm sections (to a
depth of 2000 μm to encompass some depth of follicu-
lar sectioning). Corresponding sections from the three
biopsies were pooled in separate sterile polypropylene
centrifuge tubes (Fisher Scientific, Loughborough, UK)
and the weight of each sample determined.
Quantification of CHG
Quantification of CHG was determined using a validated
high performance liquid chromatography (HPLC) method
as described previously [3, 7]. Extraction of CHG from
skin sections was carried out by the addition of 1 mL of
HPLC isocratic mobile phase [75% (v/v) HPLC grade
methanol (Fisher Scientific), 25% distilled water, 0.1% (v/v)
HPLC grade diethylamine (Sigma Aldrich), and 0.005 M
sodium heptane sulphonate (Sigma Aldrich) adjusted to
pH 4 with HPLC grade glacial acetic acid (Fisher Scien-
tific)] to each centrifuge tube containing corresponding
sections from three biopsies which were incubated at 37 °C
for one hour. All samples were then vortex-mixed for 30 s,
centrifuged for 10 min at 6000 g, filtered through a
0.45 μm filter, and the CHG quantified with an Agilent
1200 series HPLC system (Agilent Technologies, Stockport,
UK). Samples were run at room temperature at 1.2 mL/
min through a reverse-phase chromatography column
[CPS-2 Hypersil 5-μm column; 150 mm × 4.6 mm
(Fisher Scientific)] with UV detection at 254 nm. CHG
extraction was validated prior to the study and HPLC
with every run [3, 7].
Statistical analysis
To improve the validity of assumptions of normal distri-
butions, the 2% (w/v) CHG and 70% (v/v) IPA, 2% (w/v)
CHG and 70% (v/v) IPA with 2% (v/v) 1,8-cineole and
background values at each depth were log transformed.
These values were used in the statistical analysis. The
data were analysed with repeated measures analysis of
variance with two within subjects factors, a) background,
with and without 1,8-cineole and b) depth below the
skin surface. The Greenhouse-Geisser test was used to
assess the significance of F values. Repeated contrasts
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were used to compare concentrations at successive
depths. SPSS version 22 (IBM, Armonk, NY) was used
for data analysis.
Results
Background levels of CHG in full thickness skin
All the donor patients had CHG applied preoperatively
using ChloraPrep® according to manufacturer’s instruc-
tions. For samples which were not treated with any fur-
ther antiseptic material, CHG was detected in all layers
of the sectioned skin (Fig. 1). There was a significant
fall in CHG concentration between the 200–300 μm
and 300–400 μm measurements (0.667 μg/mg tissue,
P < 0.001).
Levels of CHG in full thickness skin following application
of 2% (w/v) CHG and 70% (v/v) IPA or 2% (w/v) CHG, 70%
(v/v) IPA, and 2% (v/v) 1,8-cineole
The concentration of CHG recovered from the skin at
various depths is shown in Fig. 1. In the CHG/IPA alone
group, there was a significant decrease in the CHG con-
centration with every 100 μm section skin between
100 μm and 700 μm below the skin surface (P = 0.028,
0.012, <0.001, 0.009, 0.008 and 0.026 respectively). For
the CHG/IPA with 1,8-cineole group, CHG levels de-
creased for every 100 μm depth of skin between 200 μm
and 600 μm below the skin surface (P = 0.026, 0.002,
0.010 and 0.041 respectively). The concentration of
CHG in the skin was on average significantly higher in
both the CHG/IPA and CHG/IPA with 1,8-cineole
groups compared to background levels (P = 0.015 and
P = 0.020, respectively). The size of the effect varied ac-
cording to the depth of penetration into the skin
(P = 0.004 and P = 0.011, respectively). The difference
between background and treatment values tended to de-
crease with increasing depths. The concentration of
CHG in the skin was on average significantly higher in
the CHG/IPA with 1,8-cineole group compared to the
CHG/IPA alone (P = 0.042). However the size of the ef-
fect did not vary according to the depth of penetration
into the skin (P = 0.311), with there being no evidence
that the true effect varied with depth. The concentra-
tions of CHG in the skin following application of the
CHG solution containing 1,8-cineole were on average
33.3% higher (95%, CI 1.5% - 74.9%) than when the
CHG solution without 1,8-cineole was applied.
Fig. 1 Concentration of CHG in skin following exposure to 2% CHG/70% IPA with or without 2% (v/v) 1,8-cineole. Penetration profile showing
the concentration of CHG in excised human skin (0-2000 μm depth) after exposure to 2% (w/v) CHG in 70% (v/v) IPA with and without 2% (v/v)
1,8-cineole (mean ± SEM). Background levels of CHG derived from preoperative skin antisepsis, without any further CHG added are also
presented. The purple line represents the MIC value of CHG against MRSA (N315) in a biofilm [9]. The assumption that 1 g of skin is equal to
1 mL was made. The concentration of CHG in the skin was significantly higher in the CHG/IPA with 1,8-cineole group compared to the CHG/IPA
alone (P = 0.042). The size of the effect did not vary according to the depth of penetration into the skin (P = 0.311), indicating that the
concentration of CHG was higher at all depths with the addition of 1,8-cineole
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Detection of CHG from the total applied to the skin
surface
A median of 40.46% (range = 9.99–61.89%) of the total
CHG applied to the skin surface was detected.
Discussion
In this study low levels of CHG were recovered from skin
to which no additional antiseptic was applied during experi-
mentation. This CHG originated from the 2% (w/v) CHG
in 70% (v/v) IPA pre-operative skin preparation which all
donor patients received following manufacturer’s guide-
lines, immediately prior to their surgery. The use of this
antiseptic follows recommendations for preoperative skin
preparations [2] http://hcai.dh.gov.uk/files/2011/03/2011-
03-14-HII-Prevent-Surgical-Site-infection-FINAL.pdf.
Chlorhexidine penetrates skin poorly which was exempli-
fied in this present study by the significant decrease in
CHG concentration between the 200-300 μm and 300-
400 μm sections. This may in part be due to the large mo-
lecular size of CHG or its binding to skin lipids [4]. In
addition, the combination of CHG and IPA has been re-
ported to reduce the initial skin penetration of CHG even
further after a two minute (but not a 30 min) application to
the skin surface and this may also offer an explanation for
the relatively low levels of CHG detected in the donor skin
[4]. Conversely, a synergistic effect between 1,8-cineole and
ethanol on the percutaneous absorption of diclofenac so-
dium has been observed [14]. Furthermore, it has been
demonstrated that the combination of eucalyptus oil, CHG
and IPA in a hard surface wipe reduced the time required
for removal of biofilms compared to CHG and IPA alone
[13]. This suggests that the addition of eucalyptus oil or
1,8-cineole may reduce the risk of any adverse effects on
penetration that IPA may induce.
In this study IPA- and aqueous CHG solutions were
not directly compared, however it was demonstrated
that skin penetration of CHG from the recommended
2% (w/v) CHG in 70% (v/v) IPA solution was signifi-
cantly enhanced with the addition of 2% (v/v) 1,8-cine-
ole. In addition the effect on CHG penetration by
evaporation of the IPA or loss from the skin surface by
vaporisation of some of the cineole was not determined
as we wished to emulate the clinical scenario of applying
skin antisepsis. It is thought that terpenes enhance lipo-
philic drug penetration by increasing the partition coeffi-
cient (partitioning of drug between vehicle and stratum
corneum), as well as hydrophilic drug penetration by
increasing the diffusion coefficient [15]. Partitioning 1,8-
cineole in the skin lipids is heterogeneous, leading to
both ordered and disordered areas in stratum corneum
lipids [11].
Although in vitro MIC levels of CHG were detected
down to 2000 μm below the skin surface in the presence
or absence of 1,8-cineole, it is unknown how the MIC
detected using in vitro methods relates to the MIC in
skin itself [9]. It would seem likely that antimicrobial ac-
tivity may be reduced in the skin with protein binding
and bacteria being present in biofilms, however it is cur-
rently unknown how 1,8 cineole influences CHG binding
and inactivation [9]. Indeed, although we have demon-
strated increased skin permeation of CHG in the pres-
ence of 1,8- cineole, further studies are required to
investigate if this is translated into enhanced antimicro-
bial activity (both from the CHG and synergistic com-
bination of CHG and 1,8 cineole) [9].
Conclusions
Since the composition of crude eucalyptus oil can vary
according to source, 1,8 cineole may therefore offer a
defined alternative which could be used in a licensed
skin antiseptic.
The higher concentrations of CHG detected in the
donor skin may improve the antimicrobial activity of
preoperative skin preparations thereby reducing the risk
of infection associated with procedures involving skin in-
cision Howeverfurther studies are required to investigate
if the observed enhanced CHG skin penetration results
in improved antimicrobial activity in situ.
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